SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-23-004779
Filing Date
2023-07-28
Accepted
2023-07-28 08:31:00
Documents
15
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_072823.htm 6-K 13350
2 EXHIBIT 99.1 exh_991.htm EX-99.1 228684
3 EXHIBIT 99.2 exh_992.htm EX-99.2 182977
4 EXHIBIT 99.3 exh_993.htm EX-99.3 5605
5 EXHIBIT 99.4 exh_994.htm EX-99.4 5569
6 EXHIBIT 99.5 exh_995.htm EX-99.5 10191
7 GRAPHIC logo.jpg GRAPHIC 9260
8 GRAPHIC doselvl6.jpg GRAPHIC 61926
9 GRAPHIC noevvls.jpg GRAPHIC 50563
10 GRAPHIC pkprof.jpg GRAPHIC 66606
11 GRAPHIC lympexpan.jpg GRAPHIC 66278
12 GRAPHIC stimcd8.jpg GRAPHIC 41797
13 GRAPHIC treatduration.jpg GRAPHIC 78917
14 GRAPHIC antipd1.jpg GRAPHIC 64851
15 GRAPHIC tumormodel.jpg GRAPHIC 64058
  Complete submission text file 0001171843-23-004779.txt   1143019
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-39458 | Film No.: 231120316
SIC: 2834 Pharmaceutical Preparations